Literature DB >> 24508707

Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma.

A Lacourt1, C Gramond1, P Rolland2, S Ducamp2, S Audignon1, P Astoul3, S Chamming's4, A Gilg Soit Ilg5, M Rinaldo1, C Raherison1, F Galateau-Salle6, E Imbernon7, J C Pairon8, M Goldberg9, P Brochard1.   

Abstract

OBJECTIVES: To estimate the proportion of pleural mesothelioma cases that can be attributed to asbestos exposure in France including non-occupational exposure.
METHODS: A population-based case-control study including 437 incident cases and 874 controls was conducted from 1998 to 2002. Occupational and non-occupational asbestos exposure was assessed retrospectively by two expert hygienists. ORs of pleural mesothelioma for asbestos-exposed subjects compared to non-exposed subjects, and population-attributable risk (ARp) of asbestos exposure were estimated using a conditional logistic regression.
RESULTS: A clear dose-response relationship was observed between occupational asbestos exposure and pleural mesothelioma (OR=4.0 (99% CI 1.9 to 8.3) for men exposed at less than 0.1 f/mL-year vs. 67.0 (99% CI 25.6 to 175.1) for men exposed at more than 10 f/mL-year). The occupational asbestos ARp was 83.1% (99% CI 74.5% to 91.7%) for men and 41.7% (99% CI 25.3% to 58.0%) for women. A higher risk of pleural mesothelioma was observed in subjects non-occupationally exposed to asbestos compared to those never exposed. The non-occupational asbestos ARp for these subjects was 20.0% (99% CI -33.5% to 73.5%) in men and 38.7% (99% CI 8.4% to 69.0%) in women. When considering all kinds of asbestos exposure, ARp was 87.3% (99% CI 78.9% to 95.7%) for men and 64.8% (99% CI 45.4% to 84.3%) for women.
CONCLUSIONS: Our study suggests that the overall ARp in women is largely driven by non-occupational asbestos exposure arguing for the strong impact of such exposure in pleural mesothelioma occurrence. Considering the difficulty in assessing domestic or environmental asbestos exposure, this could explain the observed difference in ARp between men and women. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24508707     DOI: 10.1136/thoraxjnl-2013-203744

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure.

Authors:  Rengyi Xu; Clementina Mesaros; Liwei Weng; Nathaniel W Snyder; Anil Vachani; Ian A Blair; Wei-Ting Hwang
Journal:  Biomark Med       Date:  2017-05-23       Impact factor: 2.851

2.  Understanding exposures and latent disease risk within the National Institute of Environmental Health Sciences Superfund Research Program.

Authors:  Sara M Amolegbe; Danielle J Carlin; Heather F Henry; Michelle L Heacock; Brittany A Trottier; William A Suk
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-07

Review 3.  Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure.

Authors:  Manuela Valenzuela; Margarita Giraldo; Sonia Gallo-Murcia; Juliana Pineda; Laura Santos; Juan Pablo Ramos-Bonilla
Journal:  Curr Environ Health Rep       Date:  2016-12

4.  Current and future risks of asbestos exposure in the Australian community.

Authors:  Corie Gray; Renee N Carey; Alison Reid
Journal:  Int J Occup Environ Health       Date:  2016-09-09

5.  Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.

Authors:  Edwin R Parra; Jie Zhai; Auriole Tamegnon; Nicolas Zhou; Renganayaki Krishna Pandurengan; Carmelia Barreto; Mei Jiang; David C Rice; Caitlin Creasy; Ara A Vaporciyan; Wayne L Hofstetter; Anne S Tsao; Ignacio I Wistuba; Boris Sepesi; Cara Haymaker
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

6.  Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry.

Authors:  Marisa Corfiati; Alberto Scarselli; Alessandra Binazzi; Davide Di Marzio; Marina Verardo; Dario Mirabelli; Valerio Gennaro; Carolina Mensi; Gert Schallemberg; Enzo Merler; Corrado Negro; Antonio Romanelli; Elisabetta Chellini; Stefano Silvestri; Mario Cocchioni; Cristiana Pascucci; Fabrizio Stracci; Elisa Romeo; Luana Trafficante; Italo Angelillo; Simona Menegozzo; Marina Musti; Domenica Cavone; Gabriella Cauzillo; Federico Tallarigo; Rosario Tumino; Massimo Melis; Sergio Iavicoli; Alessandro Marinaccio
Journal:  BMC Cancer       Date:  2015-04-15       Impact factor: 4.430

7.  Activity-Based Exposure Levels and Cancer Risk Assessment Due to Naturally Occurring Asbestos for the Residents Near Abandoned Asbestos Mines in South Korea.

Authors:  Seungho Lee; Dongmug Kang; Youngki Kim; Yoon-Ji Kim; Se-Yeong Kim
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

8.  Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast.

Authors:  Mohamed Mokhtar Desouki; Daniel Jerad Long
Journal:  Case Rep Oncol Med       Date:  2015-09-10

9.  Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma.

Authors:  Ferdinando Cerciello; Meena Choi; Sara L Sinicropi-Yao; Katie Lomeo; Joseph M Amann; Emanuela Felley-Bosco; Rolf A Stahel; Bruce W S Robinson; Jenette Creaney; Harvey I Pass; Olga Vitek; David P Carbone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-30       Impact factor: 4.254

10.  A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.

Authors:  Rumeng Gu; Luxi Jiang; Ting Duan; Chun Chen; Shengchang Wu; Deguang Mu
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.